Skip to content

Anti-oxidative effects of hydrogen rich water on severe chronic hepatitis B: a clinical study

Anti-oxidative effects of hydrogen rich water on severe chronic hepatitis B: a clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003875
Enrollment
Unknown
Registered
2013-10-28
Start date
2013-08-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Hydrogen group:Hydrogen water
Control:No

Sponsors

the Forth People's Hospital of Huai'an City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients had a history of chronic hepatitis B of >6 month or were positive for HBsAg for 6 months; patients had obvious or continuous symptoms of hepatitis (such as fatigure,poor appetite,abdominal distension, dark urine, loose stools) and signs of hepatitis (Hepatic face, liver palms, spider angiomas, splenomegaly) and repeated or continuous increase in ALT/AST. One of following items can be used to determine the severe chronic hepatitis B: (1) ALB5 times of normal upper limit; (3) PTA 40-60%; (4) CHE <2500 U/L. 2. Patients were 18-60 years old, and gender was not restricted.

Exclusion criteria

Exclusion criteria: (1) Patients had alcoholic,drug-induced, genetic,autoimmune,or metabolic hepatitis or hepatitis caused by other virus; (2) Patients had complications of hepatitis (such as upper gastrointestinal bleeding, infection,hepatic encephalopathy, ascites, electrolyte imbalance), and other diseases (such as diabetes, rheumatoid disease, coronary heart disease tumors or infection of other systems); (3) Patients had severe diseases of the heart, lung, kidney, brain or hematopoietic system or wasting diseases; (4) Patients had allergies or a history of sensitivity to several drugs; (5) Patients were pregnant or breast-breeding; patients had no self-reporting ability; patients were treated with vitamin within 6 months before study; patients were treated with anti-oxidants (such as milk thistle, tiopronin, glutathione preparations).

Design outcomes

Primary

MeasureTime frame
Liver Function;Oxidative and anti-oxidative parameter;

Countries

China

Contacts

Public ContactXia Chunxiang

The Forth People's Hospital of Huai'an City, Jiangsu Province

xiachunxiangxmx@163.com+86 13912086033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026